Acyl Cyanides as Bifunctional Reagent: Application in Copper-Catalyzed Cyanoamidation and Cyanoesterification Reaction
作者:Zhengwang Chen、Xiaowei Wen、Weiping Zheng、Ruolan He、Dou Chen、Dingsheng Cao、Lipeng Long、Min Ye
DOI:10.1021/acs.joc.9b03500
日期:2020.4.17
Cu-catalyzed domino decyanation and cyanation reaction of acyl cyanides with amines or alcohols have been developed. The cyanosources were generated in situ via C–CN cleavage yielding the corresponding cyano substituted amides or esters in moderate to excellent yields. This approach features a cheap copper catalyst, domino decyanation and cyanation reaction, readily available starting materials, broad
<scp>Iron‐Catalyzed</scp> Amide Bond Formation from Carboxylic Acids and Isocyanates<sup>†</sup>
作者:Lingjian Zi、Jing Zhang
DOI:10.1002/cjoc.202300396
日期:2023.12
We describe an iron-catalyzed amidebondformation from readily available carboxylic acids and isocyanates. This method utilizes an abundant and biocompatible iron catalyst and easily accessible starting materials, generates CO2 as the only byproduct, and features broad substrate scopes with good functional group compatibility. Therefore, it provides a cost-effective and practical protocol to access
Direct Oxidative Amidation of Aldehydes with Anilines under Mechanical Milling Conditions
作者:Jie Gao、Guan-Wu Wang
DOI:10.1021/jo800075t
日期:2008.4.1
Oxone is found to be an effective oxidant for the oxidative amidation of aldehydes with anilines to furnish amides in a one-pot process under mechanical milling conditions.
IDENTIFICATION OF NON-COVALENT COMPLEXES BY MASS SPECTROMETRY
申请人:Gadek R. Thomas
公开号:US20070141630A1
公开(公告)日:2007-06-21
Methods for identifying novel drug leads or binding compounds that have an affinity for a target molecule involving screening known drug fragment molecules and derivatives thereof, preferably using mass spectrometry are disclosed.
[EN] COMPOUNDS THAT EXPAND HEMATOPOIETIC STEM CELLS<br/>[FR] COMPOSÉS QUI DÉVELOPPENT DES CELLULES SOUCHES HÉMATOPOÏÉTIQUES
申请人:IRM LLC
公开号:WO2012102937A2
公开(公告)日:2012-08-02
The present invention relates to compounds and compositions for expanding the number of CD34+ cells for transplantation. The invention further relates to a cell population comprising expanded hematopoietic stem cells (HSCs) and its use in autologous or allogeneic transplantation for the treatment of patients with inherited immunodeficient and autoimmune diseases and diverse hematopoietic disorders to reconstitute the hematopoietic cell lineages and immune system defense.